Eden Research (LON:EDEN) Shares Down 3.3% – Here’s What Happened

Posted by Cynthia Vaughn on Feb 23rd, 2025

Eden Research plc (LON:EDEN – Get Free Report) shares dropped 3.3% during trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The stock’s 50-day moving average is GBX 3.87 and its 200 day moving average is GBX 3.95. The firm has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92.

Insider Activity at Eden Research

In related news, insider Lykele van der Broek bought 256,000 shares of Eden Research stock in a transaction that occurred on Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of Eden Research stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). 14.02% of the stock is owned by corporate insiders.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.